This community is in archive. Visit community.xprize.org for the current XPRIZE Community.
Where should we hold clinical trials?
NickOttens
Posts: 899 admin
We have identified four criteria for deciding where to hold clinical trials:
In Georgia, it only takes 6 weeks to get approval.
In Bulgaria, Colombia, Estonia, Latvia, and Lithuania, it takes 8 weeks.
In Ecuador, it takes 4 weeks to obtain approval from an ethics committee and 6 more weeks to obtain approval from the ARCSA - MoH.
In Peru, it 6 weeks to obtain approval from an ethics committee , 1 week to obtain approval for protocol from INS , and 8 weeks for the INS review and approve the clinical trial.
In Chile, approval from an ethics committee takes 13 weeks and approval from the ISP 6.5 weeks.
Malaysia markets itself as a preferred clinical trial destination. Regulatory and ethics submissions are in English. Patient costs and IRB fees are low compared to most countries. The average timeline for regulatory and IRB approval is about 3-4 months.
Which countries do you think we should consider? Are there criteria we should add, or change?
- Recruitment speed: Depends on the number of suitable, experienced sites that can be activated as well as the availability and cost of health care.
- Study cost: Expenses of labor and site fees.
- Regulatory environment: Regulatory requirements differ between countries.
- Investigator motivation: Motivation of sites and PI to participate and contribute to a clinical trial.
In Georgia, it only takes 6 weeks to get approval.
In Bulgaria, Colombia, Estonia, Latvia, and Lithuania, it takes 8 weeks.
In Ecuador, it takes 4 weeks to obtain approval from an ethics committee and 6 more weeks to obtain approval from the ARCSA - MoH.
In Peru, it 6 weeks to obtain approval from an ethics committee , 1 week to obtain approval for protocol from INS , and 8 weeks for the INS review and approve the clinical trial.
In Chile, approval from an ethics committee takes 13 weeks and approval from the ISP 6.5 weeks.
Malaysia markets itself as a preferred clinical trial destination. Regulatory and ethics submissions are in English. Patient costs and IRB fees are low compared to most countries. The average timeline for regulatory and IRB approval is about 3-4 months.
Which countries do you think we should consider? Are there criteria we should add, or change?
0
Comments
@nicolas_cher, would you recommend Brazil?
Great minds think alike! Our team is in close touch with Bobby.
@YuriDeigin, @sramek, @CarolynPorter, can I ask for your input on this question as well? What's the best country to hold clinical trials?